Nicole Longoni

发表

EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB

C. Catapano, N. Longoni, D. Albino, 2016, Molecular Cancer Therapeutics.

Photochemically enhanced delivery of a cell‐penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells

G. Sozzi, M. Daidone, N. Zaffaroni, 2007, Cell proliferation.

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

M. Daidone, N. Zaffaroni, R. Supino, 2009, Cancer research.

A positive feedback loop between ESE1/ELF3 and NF-κB promotes prostate cancer progression

N. Longoni, Nicole Longoni, 2014 .

ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features.

C. Catapano, N. Longoni, M. Sarti, 2012, Cancer research.

Surgery for pharmacoresistant epilepsy in the developing world: A pilot study

F. Andermann, R. Bittar, W. Boling, 2009, Epilepsia.

Prostate through Down-regulation of Protein Kinase C miR-205 Exerts Tumor-Suppressive Functions in Human

M. Daidone, N. Zaffaroni, R. Supino, 2009 .

Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression

C. Catapano, N. Longoni, M. Sarti, 2013, Oncogene.

miR-21: an oncomir on strike in prostate cancer

M. Daidone, M. Callari, N. Zaffaroni, 2010, Molecular Cancer.

Tumor and Stem Cell Biology ESE3/EHFControls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features

C. Catapano, N. Longoni, M. Sarti, 2012 .